An update on DPP-4 inhibitors in the management of type 2 diabetes
Author:
Publisher
Informa UK Limited
Subject
Pharmacology (medical),Pharmacology
Link
http://www.tandfonline.com/doi/pdf/10.1080/14728214.2016.1257608
Reference88 articles.
1. Pharmacology, Physiology, and Mechanisms of Incretin Hormone Action
2. Incretin-based therapies for type 2 diabetes mellitus
3. Emerging gliptins for type 2 diabetes
4. Loss of Incretin Effect Is a Specific, Important, and Early Characteristic of Type 2 Diabetes
Cited by 59 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The inhibition of DPP-4 by Plantago asiatica L. and the discovery of active compounds;Phytochemistry Letters;2024-10
2. The Roadmap of Plant Antimicrobial Peptides Under Environmental Stress: From Farm to Bedside;Probiotics and Antimicrobial Proteins;2024-09-03
3. Utilization of Glucagon-Like Peptide-1 Receptor Agonist and Dipeptidyl Peptidase-4 Inhibitors at the Veterans Health Administration;Journal of Pharmacy Technology;2024-07-27
4. Phytoconstituents Analysis and Anti-Diabetic Potential of Sembung Leaf Extract (Blumea balsamifera L. .) through Inhibition of NF-KB p65, GLP-1, and DPP-4 Proteins with In-Silico Approaches;Biomedical and Pharmacology Journal;2024-06-25
5. Synthesis and clinical application of representative small-molecule dipeptidyl Peptidase-4 (DPP-4) inhibitors for the treatment of type 2 diabetes mellitus (T2DM);European Journal of Medicinal Chemistry;2024-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3